Tech Center 1600 • Art Units: 1627 1639 1645 1654 1658 1676
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17768537 | Bi-Peptide with Affinity to Extracellular Matrix Proteins or Cells and to Growth Factors for Tissue Healing and Regeneration | Final Rejection | Mayo Foundation for Medical Education and Research |
| 17433009 | CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY | Non-Final OA | The Regents of the University of Michigan |
| 19351688 | PROCESSES AND INTERMEDIATES FOR PREPARING TIRZEPATIDE | Final Rejection | ELI LILLY AND COMPANY |
| 17760668 | Conformationally-Constrained Alpha-RGIA Analogues | Non-Final OA | University of Utah Research Foundation |
| 18037098 | VIBRIO TOXIN BINDING PROTEINS IN SHRIMP AND USES THEREOF | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 18872790 | PREVENTING ALU SINES-MEDIATED PATHOLOGIES | Non-Final OA | UNIVERSITY OF SOUTH FLORIDA |
| 17296795 | PEPTIDE LIGANDS FOR CAPTURE OF HOST CELL PROTEINS | Final Rejection | North Carolina State University |
| 18564739 | Substrate-specific adhesive peptides | Non-Final OA | HENKEL AG & CO. KGAA |
| 18265883 | METHODS OF MAKING WATER-SOLUBLE PROTEIN FORMED IN A BACTERIAL EXPRESSION SYSTEM, COMPOSITIONS, AND METHODS OF USE THEREOF | Final Rejection | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK |
| 18580971 | COMPOSITION FOR PREVENTING OR TREATING LIVER DISEASES, COMPRISING STC-1 OR DERIVATIVE THEREOF | Non-Final OA | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
| 17169835 | SEPARATION OF VWF AND VWF PROPEPTIDE BY CHROMATOGRAPHIC METHODS | Final Rejection | Takeda Pharmaceutical Company Limited |
| 17396304 | Growth Hormone-Releasing Hormone Antagonists and Uses Thereof | Final Rejection | University of Miami |
| 18426877 | Treatment of Homologous Recombination Deficient Cancers | Final Rejection | Sinai Health System |
| 18530002 | MODIFIED SERPINS FOR THE TREATMENT OF BRADYKININ-MEDIATED DISEASE | Non-Final OA | PRECLINICS GESELLSCHAFT FÜR PRÄKLINISCHE FORSCHUNG MBH |
| 18273336 | INTRANASAL FORMULATIONS AND DELIVERY OF SOMATOSTATIN MIMETICS AND USES THEREOF | Non-Final OA | NBO PHARMA INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy